5′-Nitro-indirubinoxime inhibits inflammatory response in TNF-α stimulated human umbilical vein endothelial cells

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 77-83

  Kim, Eun Jung ^a   Park, Won Hwan ^a   Ahn, Sang Gun ^b   Yoon, Jung Hoon ^b   Kim, Si Wouk ^b   Kim, Soo A ^a  

^a Dongguk University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

5 NIO; Atherosclerosis; Human vascular endothelial cell; ICAM 1; IL 8; Inflammation; MCP 1; TNF

Indexed keywords

5' NITRO INDIRUBINOXIME; CARDIOVASCULAR AGENT; INDIRUBIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; 5' NITROINDIRUBINOXIME; 5'-NITROINDIRUBINOXIME; ANTIINFLAMMATORY AGENT; CCL2 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; LIPOPOLYSACCHARIDE; OXIME; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL INFILTRATION; CELL STIMULATION; CELL STRAIN U937; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; UMBILICAL VEIN; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MALE; METABOLISM; PROTEIN TRANSPORT; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; HUMANS; INDOLES; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; OXIMES; PROTEIN TRANSPORT; RATS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77954310363     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.040     Document Type: Article

References (30)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Fan J., Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003, 10:63-71.
3. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
4. Modur V., Zimmerman G.A., Prescott S.M., et al. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and-independent mitogen-activated protein kinase cascades. J Biol Chem 1996, 271:13094-13102.
5. Satriano J.A., Shuldiner M., Hora K., et al. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993, 92:1564-1571.
6. Sica A., Wang J.M., Colotta F., et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990, 144:3034-3038.
7. Rollins B.J., Yoshimura T., Leonard E.J., et al. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990, 136:1229-1233.
8. Takeya M., Yoshimura T., Leonard E.J., et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993, 24:534-539.
9. Nelken N.A., Coughlin S.R., Gordon D., et al. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88:1121-1127.
10. Huber A.R., Kunkel S.L., Todd R.F., et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254:99-102.
11. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723.
12. Boisvert W.A., Santiago R., Curtiss L.K., et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998, 101:353-363.
13. Zhang Z.N., Liu E.K., Zheng T.L., et al. Treatment of chronic myelocytic leukemia (CML) by traditional Chinese medicine and Western medicine alternately. J Tradit Chin Med 1985, 5:246-248.
14. Xiao Z., Hao Y., Liu B., et al. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma 2002, 43:1763-1768.
15. Kim S.A., Kim Y.C., Kim S.W., et al. Antitumor activity of novel indirubin derivatives in rat tumor model. Clin Cancer Res 2007, 13:253-259.
16. Kunikata T., Tatefuji T., Aga H., et al. Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur J Pharmacol 2000, 410:93-100.
17. Koch A.E., Kunkel S.L., Pearce W.H., et al. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993, 142:1423-1431.
18. Gerszten R.E., Mach F., Sauty A., et al. Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 2000, 136:87-92.
19. Kurihara T., Warr G., Loy J., et al. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997, 186:1757-1762.
20. Gu L., Okada Y., Clinton S.K., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
21. Zhou Z., Gengaro P., Wang W., et al. Role of NF-κB and PI 3-kinase/Akt in TNF-α-induced cytotoxicity in microvascular endothelial cells. Am J Physiol Renal Physiol 2008, 295:F932-F941.
22. Carr M.W., Roth S.J., Luther E., et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994, 91:3652-3656.
23. Rollins B.J. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996, 2:198-204.
24. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
25. Poston R.N., Haskard D.O., Coucher J.R., et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992, 140:665-673.
26. Sethi G., Ahn K.S., Sandur S.K., et al. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J Biol Chem 2006, 281:23425-23435.
27. Hajra L., Evans A.I., Chen M., et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA 2000, 97:9052-9057.
28. Kempe S., Kestler H., Lasar A., et al. NF-kappa B controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res 2005, 33:5308-5319.
29. Taub D.D. Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev 1996, 7:355-376.
30. Steffens S., Mach F. Inflammation and atherosclerosis. Herz 2004, 29:741-748.